Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Advanced Melanoma
|
5 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Benign melanocytic nevus
|
20 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Childhood Leukemia
|
140 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Colon Carcinoma
|
275 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Invasive Cutaneous Melanoma
|
7 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Invasive Ductal Breast Carcinoma
|
16 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Lentigo maligna melanoma
|
6 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Malignant melanoma, metastatic
|
5 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Malignant Neoplasms
|
1641 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Malignant tumor of colon
|
688 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Melanoma recurrent
|
1 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Metastatic malignant neoplasm to brain
|
28 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Papillary thyroid carcinoma
|
204 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Secondary malignant neoplasm of lung
|
20 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Skin Neoplasms
|
9 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Stage IV Cutaneous Melanoma AJCC v6 and v7
|
4 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Stage IV Skin Melanoma
|
29 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Uveal melanoma
|
22 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Colorectal Carcinoma
|
1962 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
Cutaneous Melanoma
|
248 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2003 | 2005 | ||||||
leukemia
|
144 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
Melanocytic nevus
|
33 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
Non-Small Cell Lung Carcinoma
|
712 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
Secondary malignant neoplasm of lymph node
|
188 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2005 | 2019 |